Paul W. Hoelscher insider trades

Open-market stock purchases and sales by Paul W. Hoelscher, Director at Sagimet Biosciences Inc, from SEC Form 4 filings since Jun 27, 2014.

Recent trades

DateStockTradeValue
Jun 12, 2026SGMT Sagimet Biosciences IncBought (not open market)—

Companies traded

  • SGMT Sagimet Biosciences Inc: other filings, last Jun 12, 2026
  • RPHM Reneo Pharmaceuticals, Inc: other filings, last Jun 6, 2023
  • HZNP Horizon Therapeutics Public Ltd Co: 17 sales, last Apr 20, 2022

Get free alerts when Paul W. Hoelscher files a new trade →